RxDoctor Payments Data

Christina Blaesing, APRN

Family · Ballwin, MONPI 1316135486

Payments from drug & device makers

$1,824in general payments, 2019–2025

Across 114 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$300
  • Lilly USA, LLC$237
  • Novo Nordisk$210
  • Novartis$138
  • GSK$138
  • AbbVie$134
  • plus $666 from 16 others

What the payments were for

  • Food & beverage$1,824100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,824 in reported general payments places this provider in the 75th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$34,597
Medicare patients
205
Services billed
371

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide36$43,401
JardianceEmpagliflozin18$19,772
OzempicSemaglutide12$13,110
EliquisApixaban11$10,881
XareltoRivaroxaban14$9,935
Azelastine Hcl108$1,932
Fluticasone Propionate175$1,758
Pantoprazole Sodium84$1,150
Tizanidine Hcl146$1,097
Famotidine55$1,042
Levothyroxine Sodium90$893
Bupropion XlBupropion Hcl35$814
Mirtazapine26$780
Albuterol Sulfate HfaAlbuterol Sulfate58$739
Atorvastatin Calcium120$718

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$237$43,40136 claims
Boehringer IngelheimJardiance$49$19,77218 claims
Novo NordiskOzempic$210$13,11012 claims
PfizerEliquis$300$10,88111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,812 family providers in Missouri.

Other family in Ballwin

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →